IBRX (IBRX)
ImmunityBio (IBRX) receives a NEUTRAL rating as the stock lacks fundamental valuation data and shows only moderate options activity, leaving no clear bullish or bearish trigger.
- The stock has no PE, PB, or PS data, and no valuation floor can be calculated, making it impossible to assess intrinsic value.
- Implied volatility is 73.1%, with a neutral 52% IV rank over the past 221 days, indicating options pricing is neither cheap nor expensive.
- The floor analysis confidence is low, with zero valid floors and a suitability verdict of 'unsuitable', reinforcing the lack of a reliable price anchor.
BUY-ZONE DECISION rule signal
Sign in
RULES & ALERTS FIRING
Sign in
VALUATION
Floor Engine
YOUR WATCHLIST CONTEXT
○ anonymous· Your personal floor / golden price overlay on the live price
· Per-ticker rule alerts when this stock crosses your thresholds
· Position P&L overlay — what this ticker means inside your full portfolio
IMPLIED VOLATILITY
Earnings Reactions
| Date | Time | EPS | Surprise | Gap% | Day% | Week% |
|---|---|---|---|---|---|---|
| 2026-05-07 | BMO | -0.08 | -20.0% | -6.74% | -7.40% | -2.74% |
| 2026-02-23 | BMO | -0.06 | +37.9% | +14.37% | +12.99% | +20.00% |
| 2025-11-04 | AMC | -0.07 | +30.0% | +5.29% | +3.37% | -0.96% |
| 2025-08-05 | BMO | -0.10 | — | -0.41% | +0.00% | +2.49% |
| 2025-05-12 | BMO | -0.15 | -7.1% | +8.94% | +14.01% | +35.27% |
| 2025-03-03 | BMO | -0.08 | +38.5% | -2.67% | -13.37% | -11.55% |
| 2024-11-12 | BMO | -0.12 | +33.3% | -1.65% | -9.17% | -1.83% |
| 2024-08-12 | BMO | -0.20 | -33.3% | -1.10% | -2.64% | -11.89% |
Is IBRX (IBRX) overvalued right now?
Whether IBRX (IBRX) is overvalued depends on the lens you use: trailing P/E vs its own history, CAPE vs the broader market, earnings yield vs Treasury yields. We surface all three so you don't have to pick one in isolation.
IBRX (IBRX) — what's the SELL PUT risk profile?
Selling cash-secured puts on IBRX (IBRX) is a common income strategy, but the right strike depends on your floor price (the level you'd happily own at) and the option chain's buffer/APY tradeoff. The full ladder view (deferred to a future release) ranks candidates by buffer percentage first, then APY — see the option ladder methodology for why buffer matters more than yield in this strategy.
IBRX (IBRX) — which option strategy fits your view?
If you're bullish long-term but cautious near-term on IBRX (IBRX), SELL PUT into your floor zone collects premium while waiting for a better entry. If you already own it and are neutral-to-mildly-bullish, COVERED CALL caps upside but harvests time decay. The wrong strategy on the right ticker still loses money — match the trade to your view, not the other way around.
IBRX (IBRX) — is now a good entry?
Entry timing on IBRX (IBRX) is a function of your floor price (hard buy zone) and golden price (back-the-truck-up zone). Both are personal — set them in your watchlist and we'll alert you when the market hits either level.
FAQ
Why does IBRX show different P/E numbers on different sites?
Different data providers use different earnings windows (TTM vs forward, GAAP vs adjusted) and update at different cadences. We surface trailing P/E with a 5-year percentile rank to give context — a P/E of 30 is hot for one stock and cold for another.
Does this page show IBRX's implied volatility?
Not on this v0 page — the dedicated volatility tool covers IV with multi-source voting (IBKR + Polygon + yfinance). For pure IV lookup, use /tools/volatility. This page is for decision-stage queries that pull together valuation + portfolio context.
How is this different from Yahoo Finance or 雪球's IBRX page?
Those sites are great for raw data discovery — last price, news, headline P/E. This page is built for the second look: you've already seen a single-dimension signal somewhere else, now you need multi-dimensional decision context (your floor, the valuation percentile, your portfolio overlay) in one view, not five tabs.